Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?

H Ostmeier1, B Fuchs, F Otto

  • 1Fachklinik Hornheide, Münster, Germany.

Cancer
|June 5, 1999
PubMed
Abstract

Related Concept Videos